Showing results (331-340 of 569) with videos related to
Sort By:
Pageof 57
Proceedings of the National Academy of Sciences of the United States of America|September 17, 1996
Thrombopoietic potential and serial repopulating ability of murine hematopoietic stem cells constitutively expressing interleukin 11R G Hawley, T S Hawley, A Z Fong, et al.Blood|August 15, 2002
Efficacious immunomodulatory activity of the chemokine stromal cell-derived factor 1 (SDF-1): local secretion of SDF-1 at the tumor site serves as T-cell chemoattractant and mediates T-cell-dependent antitumor responsesKyriaki Dunussi-Joannopoulos, Krystyna Zuberek, Kathlene Runyon, et al.Cancer|October 15, 2008
Durable complete responses from therapy with combined epratuzumab and rituximab: final results from an international multicenter, phase 2 study in recurrent, indolent, non-Hodgkin lymphomaJohn P Leonard, Stephen J Schuster, Christos Emmanouilides, et al.Leukemia & Lymphoma|January 24, 2012
Bortezomib in combination with rituximab, dexamethasone, ifosfamide, cisplatin and etoposide chemoimmunotherapy in patients with relapsed and primary refractory diffuse large B-cell lymphomaRebecca L Elstrom, Biree Andemariam, Peter Martin, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2012
Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsivenessM S Czuczman, J P Leonard, S Jung, et al.Cancer|March 15, 2008
Prednisone, etoposide, procarbazine, and cyclophosphamide (PEP-C) oral combination chemotherapy regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapyMorton Coleman, Peter Martin, Jia Ruan, et al.Nucleic Acids Research|June 1, 2023
Prolonging genetic circuit stability through adaptive evolution of overlapping genesJennifer L Chlebek, Sean P Leonard, Christina Kang-Yun, et al.Biorxiv : the Preprint Server for Biology|October 3, 2023
Single-step genome engineering in the bee gut symbiont Snodgrassella alviPatrick J Lariviere, A H M Zuberi Ashraf, Sean P Leonard, et al.The New England Journal of Medicine|November 5, 2010
Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomasAnas Younes, Nancy L Bartlett, John P Leonard, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
Re-treatment with I-131 tositumomab in patients with non-Hodgkin's lymphoma who had previously responded to I-131 tositumomabMark S Kaminski, John A Radford, Stephanie A Gregory, et al.Pageof 57